We are live on ! Find out more
PTCT icon

PTC Therapeutics
PTCT

123 hedge funds and large institutions have $313M invested in PTC Therapeutics in 2016 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 33 increasing their positions, 44 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

122% more call options, than puts

Call options by funds: $18.2M | Put options by funds: $8.2M

83.56% more ownership

Funds ownership: 0% → 83.56% (+84%)

41% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 22

7% more funds holding

Funds holding: 115 → 123 (+8)

23% less capital invested

Capital invested by funds: $408M → $313M (-$94.6M)

25% less repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 44

Holders
123
Holders Change
+8
Holders Change %
+6.96%
% of All Funds
3.08%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
31
Increased
33
Reduced
44
Closed
22
Calls
$18.2M
Puts
$8.2M
Net Calls
+$10M
Net Calls Change
+$4.63M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$13.5M
2
RI
RTW Investments
New York
+$10.5M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$7.89M
4
KCM
Kingdon Capital Management
New York
+$6.35M
5
NI
Numeric Investors
Massachusetts
+$5.96M

Top Sellers

Rank Fund Capital Flow
1
CCM
Camber Capital Management
Massachusetts
-$28M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$11.5M
3
Renaissance Technologies
Renaissance Technologies
New York
-$7.74M
4
SAM
Sectoral Asset Management
Quebec, Canada
-$6.89M
5
Franklin Resources
Franklin Resources
California
-$5.57M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$3.22M +$2.76M +263,510 +834%
TA
27
Teachers Advisors
New York
$3M +$2.34M +223,033 +426%
Geode Capital Management
28
Geode Capital Management
Massachusetts
$2.83M +$316K +30,111 +13%
Ameriprise
29
Ameriprise
Minnesota
$2.83M -$2.19M -208,596 -45%
QI
30
QS Investors
New York
$2.46M – – –
O
31
OrbiMed
New York
$2.23M +$2.14M +204,400 New
SDIC
32
South Dakota Investment Council
South Dakota
$1.98M -$182K -17,389 -9%
PCM
33
Prelude Capital Management
New York
$1.98M -$367K -34,947 -16%
BIM
34
BlackRock Investment Management
Delaware
$1.77M -$201K -19,197 -11%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$1.77M -$54.8K -5,219 -3%
PP
36
PDT Partners
New York
$1.76M -$52.5K -5,000 -3%
SFM
37
Sphera Funds Management
Israel
$1.64M +$1.57M +150,000 New
CWG
38
C WorldWide Group
Denmark
$1.58M -$161K -15,378 -10%
OAM
39
Oxford Asset Management
United Kingdom
$1.49M +$1.43M +136,592 New
BG
40
BlackRock Group
United Kingdom
$1.47M -$670K -63,866 -32%
Susquehanna International Group
41
Susquehanna International Group
Pennsylvania
$1.43M +$1.38M +131,449 New
ARTA
42
A.R.T. Advisors
New York
$1.37M +$1.32M +125,700 New
SAM
43
Sectoral Asset Management
Quebec, Canada
$1.34M -$6.89M -656,863 -84%
Charles Schwab
44
Charles Schwab
California
$1.3M +$64.6K +6,160 +5%
CCI
45
Columbus Circle Investors
$1.19M +$729K +69,532 +175%
TCIM
46
TIAA CREF Investment Management
New York
$1.02M -$139K -13,258 -12%
Invesco
47
Invesco
Georgia
$964K +$927K +88,321 New
Fisher Asset Management
48
Fisher Asset Management
Washington
$958K -$18.9K -1,800 -2%
PPA
49
Parametric Portfolio Associates
Washington
$902K +$409K +38,996 +89%
QIM
50
Quantitative Investment Management
Virginia
$897K +$366K +34,900 +74%
1
2
3 4 5

PTCT Hedge Fund Activity: Q4 2016 in Review

123 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in PTC Therapeutics (PTCT) for Q4 2016, worth a combined $313M — down 23% from $408M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new PTCT positions and 22 closed out — a net gain of 9 holders — while 33 added to existing stakes and 44 trimmed.

The largest buyer was Millennium Management, adding an estimated $13.5M. The largest seller was Camber Capital Management, exiting entirely with an estimated $28M sold.

  • 123 institutional investors held PTC Therapeutics (PTCT) as of Q4 2016, up from 115 in Q3 2016.
  • Funds reported $313M of PTC Therapeutics stock for Q4 2016, down 23% quarter-over-quarter.
  • 31 funds opened new PTC Therapeutics positions in Q4 2016 and 22 closed out, a net change of +9 holders.
  • The largest PTC Therapeutics buyer in Q4 2016 was Millennium Management, an estimated $13.5M added.
  • The largest PTC Therapeutics seller in Q4 2016 was Camber Capital Management, an estimated $28M sold.

Based on aggregated 13F filings for Q4 2016.